Table 2.

¹H and ¹³C NMR data of sanguinamide B, 8 (600 MHz, CDCl₃)

	#	δCa, mult.	δH, mult. (J in Hz)	HMBC b
L-Val
	1	159.1, qC
	2	58.7, CH	4.61, d (6.0)	1
	3	30.6, CH	2.93, m
	4	20.4, CH3	0.87, d (6.6)
	5	20.2, CH3	1.15, d (6.6)
	- NH		9.26, d (6.6)	2, 3, 6
L-Pro-1
	6	170.4, qC
	7	60.9, CH	4.39, d (6.6)	6, 11
	8	29.4, CH2	1.74, 2.80, m	6
	9	25.2, CH2	2.22, 1.94, m
	10	45.4, CH2	3.75, 3.34, m
Oxz
	11	169.2, qC
	12	136.7, qC
	13	141.5, CH	8.27, s	12, 14
	14	157.7, qC
Thz-1
	15	142.3, qC
	16	121.8, CH	7.95, s	14, 15, 17
	17	172.9, qC
L-Pro-2
	18	58.7, CH	4.57, d (6.0)	17, 22
	19	31.1, CH2	2.94, 2.07, m	17
	20	28.7, CH2	2.10, 1.81, m
	21	48.0, CH2	3.81, 3.97, m
L- Leu
	22	170.8, qC
	23	48.4, CH	5.29, dd (16.8, 7.8)	22, 28
	24	41.4, CH	2.02, m
	25	25.6, CH2	1.63, m
	26	23.2, CH3	0.99, d (6.6)
	27	22.0, CH3	1.03, d (6.7)
	-NH		9.60, d (7.2)
Thz-2
	28	160.1, qC
	29	149.2, qC
	30	124.1, CH	8.12, s	28, 29, 31
	31	170.6, qC
L-Ala
	32	47.8, CH	5.56, qd (7.2 6.6)	1, 31
	33	24.8, CH3	1.68, d (6.6)	31
	-NH		8.42, d (7.2)	1, 31

^aδ’s measured by indirect detection, HSQC and HMBC (¹J_CH= 6 Hz)

^{b 1}H->¹³C